Artemisinin is a drug, widely used in malaria treatment. As the binding affinity of artemisinin and its derivatives dihydroartemisinin and artesunate to blood serum proteins might influence the effectiveness of the drug, binding of artemisinin and derivatives to serum albumin was studied under near physiological conditions. Binding kinetics indicate a simple, single-step association process for all artemisinin derivatives. The determined changes in enthalpy and entropy upon drug binding clearly indicate that hydrophobic forces are most important for artemisinin and dihydroartemisinin binding, whereas binding of artesunate is governed by both hydrophilic and hydrophobic forces. Key residues, which are most likely involved in binding of the respective compounds, were identified in subsequent protein/drug docking studies. The obtained results not only explain differences in between artemisinin and derivatives but generally illustrate how slight modifications in a drug can significantly affect principles underlying drug binding to target proteins.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.phymed.2013.04.003 | DOI Listing |
Zhongguo Zhong Yao Za Zhi
September 2024
Tianjin Hospital, Tianjin University (Tianjin Hospital) Tianjin 300211, China Tianjin Institute of Orthopedics Tianjin 300050, China Tianjin Key Laboratory of Orthopedic Biomechanics and Medical Engineering Tianjin 300050, China.
As research into the mechanisms of orthopedic diseases continues to deepen, the shortcomings of traditional single-target the-rapies are becoming increasingly apparent. Consequently, the search for multi-target drugs has become the mainstream research direction for orthopedics-related diseases. Artemisinin, a sesquiterpene lactone compound extracted from Artemisia annua, has led to the gradual synthesis of various derivatives such as dihydroartemisinin, artesunate, artemether, and arteether.
View Article and Find Full Text PDFMicrob Pathog
December 2024
Clinical Immunology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran. Electronic address:
PLoS One
December 2024
School of Allied Health Sciences, Walailak University, Nakhon Si Thammarat, Thailand.
The increased resistance of Plasmodium falciparum to artemisinin and its partner drugs poses a serious challenge to global malaria control and elimination programs. This study aimed to investigate the therapeutic potential of Mesua ferrea Linn., a medicinal plant, as a source for novel antimalarial compounds.
View Article and Find Full Text PDFInflammation
November 2024
Centre for Immuno-Biology and Immunotherapy, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, 3rd Milestone, Faridabad-Gurgaon Expressway, Faridabad, 121001, Haryana, India.
Artemisinin and its derivatives, used as front-line anti-malarial drugs, exhibit anti-inflammatory properties. They were found to suppress the generation and function of Th1 and Th17 cells while promoting the generation of Foxp3 + regulatory T cells (Tregs). However, the specific role of Artemotil (β-arteether) in modulating the generation and functions of CD4 + T cells, particularly Type 1 regulatory T cells (Tr1), remains to be explored.
View Article and Find Full Text PDFPharmaceutics
November 2024
Department of Infection and Immunity, King Faisal Specialist Hospital & Research Center, Riyadh 11211, Saudi Arabia.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!